CCR5 Inhibitors and HIV-1 Infection

Ítems similars

• Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc
  per: Latinovic, Olga, et al.
  Publicat: (2009)
• CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells
  per: Latinovic, Olga, et al.
  Publicat: (2011)
• Synergistic Inhibition of R5 HIV-1 by Maraviroc and CCR5 Antibody HGS004 in Primary Cells: Implications for Treatment and Prevention
  per: LATINOVIC, OLGA, et al.
  Publicat: (2011)
• Use of Humanized Mouse Models for Studying HIV-1 Infection, Pathogenesis and Persistence
  per: Weichseldorfer, Matthew, et al.
  Publicat: (2020)
• Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1
  per: Heredia, Alonso, et al.
  Publicat: (2008)